Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone

Por Cristofanilli, Massimo
Publicado em 2012

Circulating tumor cells in breast cancer: Advanced tools for “tailored” therapy?

Por Cristofanilli, Massimo, Mendelsohn, John
Publicado em 2006

Molecular characterization and targeted therapeutic approaches in breast cancer

Por Toss, Angela, Cristofanilli, Massimo
Publicado no Breast Cancer Res (2015)

Circulating tumor cells in breast cancer: A tool whose time has come of age

Por Swaby, Ramona F, Cristofanilli, Massimo
Publicado em 2011

The Third International Inflammatory Breast Cancer Conference

Por van Golen, Kenneth L, Cristofanilli, Massimo
Publicado em 2013

Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis

Por Dong, Xiaoshen, Alpaugh, Katherine R., Cristofanilli, Massimo
Publicado em 2012

CTC enumeration and characterization: moving toward personalized medicine

Por Toss, Angela, Mu, Zhaomei, Fernandez, Sandra, Cristofanilli, Massimo
Publicado no Ann Transl Med (2014)

Recurrent granulomatous mastitis mimicking inflammatory breast cancer

Por Ergin, Ahmet Bahadir, Cristofanilli, Massimo, Daw, Hamed, Tahan, Gulgun, Gong, Yun
Publicado em 2011

Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator...

Por Ogony, Joshua, Choi, Hye Joung, Lui, Asona, Cristofanilli, Massimo, Lewis-Wambi, Joan
Publicado no Breast Cancer Res (2016)

Dyadic Coping in Metastatic Breast Cancer

Por Badr, Hoda, Carmack, Cindy L., Kashy, Deborah A., Cristofanilli, Massimo, Revenson, Tracey A.
Publicado em 2010

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells

Por Mu, Zhaomei, Li, Hua, Fernandez, Sandra V, Alpaugh, Katherine R, Zhang, Rugang, Cristofanilli, Massimo
Publicado em 2013

Differential Regulation of The Aggressive Phenotype of Inflammatory Breast Cancer Cells By Prostanoid Receptors EP3 and EP4

Por Robertson, Fredika M., Simeone, Ann-Marie, Lucci, Anthony, McMurray, John S., Ghosh, Sukhen, Cristofanilli, Massimo
Publicado em 2010

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast...

Por Mu, Zhaomei, Klinowska, Teresa, Dong, Xiaoshen, Foster, Emily, Womack, Chris, Fernandez, Sandra V, Cristofanilli, Massimo
Publicado em 2014

A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process

Por Wurth, Roberto, Tarn, Kevin, Jernigan, Danielle, Fernandez, Sandra V., Cristofanilli, Massimo, Fatatis, Alessandro, Meucci, Olimpia
Publicado no Transl Oncol (2015)

Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups

Por Yao, Katharine, Goldschmidt, Robert, Turk, Mary, Wesseling, Jelle, Stork-Sloots, Lisette, de Snoo, Femke, Cristofanilli, Massimo
Publicado no Breast Cancer Res Treat (2015)

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients

Por Fernandez, Sandra V, Bingham, Catherine, Fittipaldi, Patricia, Austin, Laura, Palazzo, Juan, Palmer, Gary, Alpaugh, Katherine, Cristofanilli, Massimo
Publicado no Breast Cancer Res (2014)

Aldehyde Dehydrogenase1 Immunohistochemical Staining in Primary Breast Cancer Cells Independently Predicted Overall Survival But Did Not Correlate with the Presence of Circulating...

Por Woodward, Wendy A., Krishnamurthy, Savitri, Lodhi, Ashutosh, Xiao, Lianchun, Gong, Yun, Cristofanilli, Massimo, Buchholz, Thomas A., Lucci, Anthony
Publicado em 2014

Serum HER2 levels determined by two methods in patients with metastatic breast cancer

Por Hayashi, Naoki, Nakamura, Seigo, Tokuda, Yasuharu, Yagata, Hiroshi, Yoshida, Atsushi, Ota, Hidekazu, Hortobagyi, Gabriel N., Cristofanilli, Massimo, Ueno, Naoto T.
Publicado em 2011

Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network (NCCN): The Disease, The Recurrence Pattern, and The Outcome

Por Matro, Jennifer M., Li, Tianyu, Cristofanilli, Massimo, Hughes, Melissa E., Ottesen, Rebecca A., Weeks, Jane C., Wong, Yu-Ning
Publicado no Clin Breast Cancer (2014)

Imaging and Dosimetry of (99m)Tc EC Annexin V: Preliminary Clinical Study Targeting Apoptosis in Breast Tumors

Por Kurihara, Hiroaki, Yang, David J., Cristofanilli, Massimo, Erwin, William D., Yu, Dong-Fang, Kohanim, Saady, Mendez, Richard, Kim, E. Edmund
Publicado em 2008